FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35245711000001106: Lamivudine 150mg tablets (Milpharm Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Apr 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106653601000001110 Lamivudine 150mg tablets (Milpharm Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106653701000001117 Lamivudine 150mg tablets (Milpharm Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamivudine 150mg tablets (Milpharm Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Is a Product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Has active ingredient Lamivudine false Inferred relationship Existential restriction modifier 1
Lamivudine 150mg tablets (Milpharm Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Has basis of strength substance Lamivudine true Inferred relationship Existential restriction modifier 1
Lamivudine 150mg tablets (Milpharm Ltd) Has presentation strength numerator value 150 false Inferred relationship Existential restriction modifier 1
Lamivudine 150mg tablets (Milpharm Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Lamivudine 150mg tablets (Milpharm Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Lamivudine 150mg tablets (Milpharm Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Lamivudine 150mg tablets (Milpharm Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Has specific active ingredient Lamivudine true Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Lamivudine 150mg tablets (Milpharm Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lamivudine 150mg tablets (Milpharm Ltd) 60 tablet Has AMP True Lamivudine 150mg tablets (Milpharm Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start